mtm laboratories appoints Bob Silverman as CEO
Dr Gerald Möller, Chairman of mtm laboratories' supervisory board commented:
"Bob joined us at a pivotal point when mtm was preparing to bring its first products to the market and has played a key role in the successful commercialization of CINtec® Histology, CINtec® Cytology and the Cervatec(TM) Assay. His contributions have been crucial to the evolution of mtm into an integrated, global operation. We are confident that he possesses the skills and the leadership qualities to take mtm to the next stage in the development and commercialization of mtm's products."
Bob Silverman, new Chief Executive Officer of mtm laboratories, commented on his appointment: "I am honored to be stepping into the role of CEO at mtm laboratories. And, I am appreciative of the role that Dr. Pack has played in bringing mtm and its technologies from groundbreaking discovery right up to commercialization."
Dr. Peter Pack, who hands over as CEO to Bob Silverman, added: "Over the past few years, mtm laboratories has emerged as a fully integrated diagnostics company. Bob brings a strong commercial dimension and international leadership to the Company, and I wish him and mtm every success."
Heidelberg will continue to be the Company's headquarters though Mr Silverman is based at the US subsidiary in Westborough, Massachusetts.
Other news from the department people
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.